Jyseleca

Alfasigma to acquire Galapagos’ Jyseleca business
Pharmaceutical Business Review
Tue, 01/2/24 - 09:58 am
Galapagos
Alfasigma
Jyseleca
filgotinib
ulcerative colitis
rheumatoid arthritis
Galapagos plans to cut 100 jobs after striking deal to transfer Jyseleca, 400 staffers to Alfasigma
Fierce Pharma
Tue, 10/31/23 - 11:28 am
Galapagos
Jyseleca
Alfasigma
layoffs
Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor
Fierce Pharma
Fri, 02/10/23 - 11:09 am
Galapagos
FDA
filgotinib
Crohn's Disease
clinical trials
Jyseleca
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Clinical Trials Arena
Tue, 08/9/22 - 06:32 am
clinical trials
psoriasis
psoriatic arthritis
Lipidor
AKP-02
Amgen
ABP-654
Hengyi
HPP-737
Galapagos
Jyseleca
Galapagos’ Jyseleca gets UK marketing authorization for ulcerative colitis
Pharmaceutical Business Review
Wed, 01/19/22 - 10:57 am
Galapagos
UK
ulcerative colitiis
Jyseleca
filgotinib